Therefore, we hypothesised that enhanced circulating leptin concentrations, particularly in subjects with obesity or type 2 diabetes mellitus, may contribute to several comorbidities, such as renal injury or cardiovascular disease [79,80]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.